<PAGE>
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
SCHEDULE 13G
(RULE 13d-102)
INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT
TO RULES 13d-1(b) AND (c) AND AMENDMENTS THERETO FILED
PURSUANT TO 13D-2(b)
(AMENDMENT NO. _______)
Coram Healthcare Corporation
- --------------------------------------------------------------------------------
(Name of Issuer)
Common Stock, $.001 par value
- --------------------------------------------------------------------------------
(Title of Class of Securities)
218103109
- --------------------------------------------------------------------------------
(CUSIP Number)
June 30, 1998
- --------------------------------------------------------------------------------
(Date of Event which Required Filing of this Statement)
Check the appropriate box to designate the rule pursuant to which this Schedule
is filed:
/ / Rule 13d-1(b)
/x/ Rule 13d-1(c)
/ / Rule 13d-1(d)
<PAGE>
- ---------------------------- ---------------------------
CUSIP No. 218103109 Page 2 of 15 Pages
- ---------------------------- ---------------------------
SCHEDULE 13G
- --------------------------------------------------------------------------------
1 NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON (ENTITIES ONLY)
FOOTHILL CAPITAL CORPORATION
- --------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) /x/
(b) / /
- --------------------------------------------------------------------------------
3 SEC USE ONLY
- --------------------------------------------------------------------------------
4 CITIZENSHIP OR PLACE OF ORGANIZATION
CALIFORNIA
- --------------------------------------------------------------------------------
5 SOLE VOTING POWER
- 0 -
NUMBER OF ------------------------------------------------------------
SHARES 6 SHARED VOTING POWER
BENEFICIALLY
OWNED BY 494,613(1) (SEE ITEM 4)
EACH ------------------------------------------------------------
REPORTING 7 SOLE DISPOSITIVE POWER
PERSON - 0 -
WITH ------------------------------------------------------------
8 SHARED DISPOSITIVE POWER
494,613(1) (SEE ITEM 4)
- --------------------------------------------------------------------------------
9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
494,613(1)
- --------------------------------------------------------------------------------
10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES* / /
- --------------------------------------------------------------------------------
11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
1.0%(2)
- --------------------------------------------------------------------------------
12 TYPE OF REPORTING PERSON*
CO
- --------------------------------------------------------------------------------
*SEE INSTRUCTIONS BEFORE FILLING OUT!
- -----------------------
(1) These shares are issuable upon conversion of the Company's Series B Senior
Subordinated Convertible Notes (the "Series B Notes") at a conversion price
of $3.00 per share of Common Stock, subject to downward adjustment. The
Series B Notes have a term of 10 years.
(2) Assuming issuance of Common Stock upon conversion of the Series B Notes.
<PAGE>
- ---------------------------- ---------------------------
CUSIP No. 218103109 Page 3 of 15 Pages
- ---------------------------- ---------------------------
SCHEDULE 13G
- --------------------------------------------------------------------------------
1 NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON (ENTITIES ONLY)
THE FOOTHILL GROUP, INC.
- --------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) /x/
(b) / /
- --------------------------------------------------------------------------------
3 SEC USE ONLY
- --------------------------------------------------------------------------------
4 CITIZENSHIP OR PLACE OF ORGANIZATION
DELAWARE
- --------------------------------------------------------------------------------
5 SOLE VOTING POWER
- 0 -
---------------------------------------------------------
6 SHARED VOTING POWER
NUMBER OF
SHARES 5,495,707(1) (SEE ITEM 4)
BENEFICIALLY ---------------------------------------------------------
OWNED BY 7 SOLE DISPOSITIVE POWER
EACH
REPORTING - 0 -
PERSON -------------------------------------------------------
WITH 8 SHARED DISPOSITIVE POWER
5,495,707(1) (SEE ITEM 4)
- --------------------------------------------------------------------------------
9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
5,495,707(1) (SEE ITEM 4)
- --------------------------------------------------------------------------------
10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES* / /
- --------------------------------------------------------------------------------
11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
10.12%(2)
- --------------------------------------------------------------------------------
12 TYPE OF REPORTING PERSON*
CO
- --------------------------------------------------------------------------------
*SEE INSTRUCTIONS BEFORE FILLING OUT!
- ------------------------
(1) These shares are issuable upon conversion of the Series B Notes at a
conversion price of $3.00 per share of Common Stock, subject to downward
adjustment. The Series B Notes have a term of 10 years.
(2) Assuming issuance of Common Stock upon conversion of the Series B Notes.
<PAGE>
- ---------------------------- ---------------------------
CUSIP No. 218103109 Page 4 of 15 Pages
- ---------------------------- ---------------------------
SCHEDULE 13G
- --------------------------------------------------------------------------------
1 NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON (ENTITIES ONLY)
FOOTHILL PARTNERS II, L.P.
- --------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) /x/
(b) / /
- --------------------------------------------------------------------------------
3 SEC USE ONLY
- --------------------------------------------------------------------------------
4 CITIZENSHIP OR PLACE OF ORGANIZATION
DELAWARE
- --------------------------------------------------------------------------------
5 SOLE VOTING POWER
- 0 -
---------------------------------------------------------
NUMBER OF 6 SHARED VOTING POWER
SHARES
BENEFICIALLY 5,001,094(1) (SEE ITEM 4)
OWNED BY ---------------------------------------------------------
EACH 7 SOLE DISPOSITIVE POWER
REPORTING
PERSON - 0 -
WITH ---------------------------------------------------------
8 SHARED DISPOSITIVE POWER
5,001,094(1) (SEE ITEM 4)
- --------------------------------------------------------------------------------
9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
5,001,094(1) (SEE ITEM 4)
- --------------------------------------------------------------------------------
10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES* / /
- --------------------------------------------------------------------------------
11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
9.29%(2)
- --------------------------------------------------------------------------------
12 TYPE OF REPORTING PERSON*
PN
- --------------------------------------------------------------------------------
*SEE INSTRUCTIONS BEFORE FILLING OUT!
- ------------------------
(1) These shares are issuable upon conversion of the Series B Notes at a
conversion price of $3.00 per share of Common Stock, subject to downward
adjustment. The Series B Notes have a term of 10 years.
(2) Assuming issuance of Common Stock upon conversion of the Series B Notes.
<PAGE>
- ---------------------------- ---------------------------
CUSIP No. 218103109 Page 5 of 15 Pages
- ---------------------------- ---------------------------
SCHEDULE 13G
- --------------------------------------------------------------------------------
1 NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON (ENTITIES ONLY)
M. EDWARD STEARNS
- --------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) /x/
(b) / /
- --------------------------------------------------------------------------------
3 SEC USE ONLY
- --------------------------------------------------------------------------------
4 CITIZENSHIP OR PLACE OF ORGANIZATION
CALIFORNIA
- --------------------------------------------------------------------------------
5 SOLE VOTING POWER
- 0 -
-------------------------------------------------------
NUMBER OF 6 SHARED VOTING POWER
SHARES
BENEFICIALLY 5,001,094(1) (SEE ITEM 4)
OWNED BY -------------------------------------------------------
EACH 7 SOLE DISPOSITIVE POWER
REPORTING
PERSON - 0 -
WITH -------------------------------------------------------
8 SHARED DISPOSITIVE POWER
5,001,094(1) (SEE ITEM 4)
- --------------------------------------------------------------------------------
9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
5,001,094(1) (SEE ITEM 4)
- --------------------------------------------------------------------------------
10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES* / /
- --------------------------------------------------------------------------------
11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
9.29%(2)
- --------------------------------------------------------------------------------
12 TYPE OF REPORTING PERSON*
IN
- --------------------------------------------------------------------------------
*SEE INSTRUCTIONS BEFORE FILLING OUT!
- ------------------------
(1) These shares are issuable upon conversion of the Series B Notes at a
conversion price of $3.00 per share of Common Stock, subject to downward
adjustment. The Series B Notes have a term of 10 years.
(2) Assuming issuance of Common Stock upon conversion of the Series B Notes.
<PAGE>
- ---------------------------- ---------------------------
CUSIP No. 218103109 Page 6 of 15 Pages
- ---------------------------- ---------------------------
SCHEDULE 13G
- --------------------------------------------------------------------------------
1 NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON (ENTITIES ONLY)
KAREN S. SANDLER
- --------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) /x/
(b) / /
- --------------------------------------------------------------------------------
3 SEC USE ONLY
- --------------------------------------------------------------------------------
4 CITIZENSHIP OR PLACE OF ORGANIZATION
CALIFORNIA
- --------------------------------------------------------------------------------
5 SOLE VOTING POWER
- 0 -
----------------------------------------------------------
NUMBER OF 6 SHARED VOTING POWER
SHARES
BENEFICIALLY 5,001,094(1) (SEE ITEM 4)
OWNED BY ----------------------------------------------------------
EACH 7 SOLE DISPOSITIVE POWER
REPORTING
PERSON - 0 -
WITH ----------------------------------------------------------
8 SHARED DISPOSITIVE POWER
5,001,094(1) (SEE ITEM 4)
- --------------------------------------------------------------------------------
9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
5,001,094(1) (SEE ITEM 4)
- --------------------------------------------------------------------------------
10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES* / /
- --------------------------------------------------------------------------------
11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
9.29%(2)
- --------------------------------------------------------------------------------
12 TYPE OF REPORTING PERSON*
IN
- --------------------------------------------------------------------------------
*SEE INSTRUCTIONS BEFORE FILLING OUT!
- ------------------------
(1) These shares are issuable upon conversion of the Series B Notes at a
conversion price of $3.00 per share of Common Stock, subject to downward
adjustment. The Series B Notes have a term of 10 years.
(2) Assuming issuance of Common Stock upon conversion of the Series B Notes.
<PAGE>
- ---------------------------- ---------------------------
CUSIP No. 218103109 Page 7 of 15 Pages
- ---------------------------- ---------------------------
SCHEDULE 13G
- --------------------------------------------------------------------------------
1 NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON (ENTITIES ONLY)
DENNIS R. ASCHER
- --------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) /x/
(b) / /
- --------------------------------------------------------------------------------
3 SEC USE ONLY
- --------------------------------------------------------------------------------
4 CITIZENSHIP OR PLACE OF ORGANIZATION
CALIFORNIA
- --------------------------------------------------------------------------------
5 SOLE VOTING POWER
- 0 -
--------------------------------------------------------
NUMBER OF 6 SHARED VOTING POWER
SHARES
BENEFICIALLY 5,001,094(1) (SEE ITEM 4)
OWNED BY --------------------------------------------------------
EACH 7 SOLE DISPOSITIVE POWER
REPORTING
PERSON - 0 -
WITH --------------------------------------------------------
8 SHARED DISPOSITIVE POWER
5,001,094(1) (SEE ITEM 4)
- --------------------------------------------------------------------------------
9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
5,001,094(1) (SEE ITEM 4)
- --------------------------------------------------------------------------------
10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES* / /
- --------------------------------------------------------------------------------
11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
9.29%(2)
- --------------------------------------------------------------------------------
12 TYPE OF REPORTING PERSON*
IN
- --------------------------------------------------------------------------------
*SEE INSTRUCTIONS BEFORE FILLING OUT!
- ------------------------
(1) These shares are issuable upon conversion of the Series B Notes at a
conversion price of $3.00 per share of Common Stock, subject to downward
adjustment. The Series B Notes have a term of 10 years.
(2) Assuming issuance of Common Stock upon conversion of the Series B Notes.
<PAGE>
- ---------------------------- ---------------------------
CUSIP No. 218103109 Page 8 of 15 Pages
- ---------------------------- ---------------------------
SCHEDULE 13G
- --------------------------------------------------------------------------------
1 NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON (ENTITIES ONLY)
PETER E. SCHWAB
- --------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) /x/
(b) / /
- --------------------------------------------------------------------------------
3 SEC USE ONLY
- --------------------------------------------------------------------------------
4 CITIZENSHIP OR PLACE OF ORGANIZATION
CALIFORNIA
- --------------------------------------------------------------------------------
5 SOLE VOTING POWER
- 0 -
---------------------------------------------------------
NUMBER OF
SHARES 6 SHARED VOTING POWER
BENEFICIALLY
OWNED BY 5,001,094(1) (SEE ITEM 4)
EACH ---------------------------------------------------------
REPORTING 7 SOLE DISPOSITIVE POWER
PERSON
WITH - 0 -
---------------------------------------------------------
8 SHARED DISPOSITIVE POWER
5,001,094(1) (SEE ITEM 4)
- --------------------------------------------------------------------------------
9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
5,001,094(1) (SEE ITEM 4)
- --------------------------------------------------------------------------------
10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES* / /
- --------------------------------------------------------------------------------
11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
9.29%(2)
- --------------------------------------------------------------------------------
12 TYPE OF REPORTING PERSON*
IN
- --------------------------------------------------------------------------------
*SEE INSTRUCTIONS BEFORE FILLING OUT!
- ------------------------
(1) These shares are issuable upon conversion of the Series B Notes at a
conversion price of $3.00 per share of Common Stock, subject to downward
adjustment. The Series B Notes have a term of 10 years.
(2) Assuming issuance of Common Stock upon conversion of the Series B Notes.
<PAGE>
- ---------------------------- ---------------------------
CUSIP No. 218103109 Page 9 of 15 Pages
- ---------------------------- ---------------------------
SCHEDULE 13G
- --------------------------------------------------------------------------------
1 NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON (ENTITIES ONLY)
DAVID C. HILTON
- --------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) /x/
(b) / /
- --------------------------------------------------------------------------------
3 SEC USE ONLY
- --------------------------------------------------------------------------------
4 CITIZENSHIP OR PLACE OF ORGANIZATION
CALIFORNIA
- --------------------------------------------------------------------------------
5 SOLE VOTING POWER
- 0 -
NUMBER OF ----------------------------------------------------------
SHARES 6 SHARED VOTING POWER
BENEFICIALLY
OWNED BY 5,001,094(1) (SEE ITEM 4)
EACH ----------------------------------------------------------
REPORTING 7 SOLE DISPOSITIVE POWER
PERSON
WITH - 0 -
----------------------------------------------------------
8 SHARED DISPOSITIVE POWER
5,001,094(1) (SEE ITEM 4)
- --------------------------------------------------------------------------------
9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
5,001,094(1) (SEE ITEM 4)
- --------------------------------------------------------------------------------
10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES* / /
- --------------------------------------------------------------------------------
11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
9.29%(2)
- --------------------------------------------------------------------------------
12 TYPE OF REPORTING PERSON*
IN
- --------------------------------------------------------------------------------
*SEE INSTRUCTIONS BEFORE FILLING OUT!
- ------------------------
(1) These shares are issuable upon conversion of the Series B Notes at a
conversion price of $3.00 per share of Common Stock, subject to downward
adjustment. The Series B Notes have a term of 10 years.
(2) Assuming issuance of Common Stock upon conversion of the Series B Notes.
<PAGE>
- ---------------------------- ---------------------------
CUSIP No. 218103109 Page 10 of 15 Pages
- ---------------------------- ---------------------------
SCHEDULE 13G
- --------------------------------------------------------------------------------
1 NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON (ENTITIES ONLY)
JEFFREY T. NIKORA
- --------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) /x/
(b) / /
- --------------------------------------------------------------------------------
3 SEC USE ONLY
- --------------------------------------------------------------------------------
4 CITIZENSHIP OR PLACE OF ORGANIZATION
CALIFORNIA
- --------------------------------------------------------------------------------
5 SOLE VOTING POWER
- 0 -
NUMBER OF -----------------------------------------------------------
SHARES 6 SHARED VOTING POWER
BENEFICIALLY
OWNED BY 5,001,094(1) (SEE ITEM 4)
EACH -----------------------------------------------------------
REPORTING 7 SOLE DISPOSITIVE POWER
PERSON
WITH - 0 -
-----------------------------------------------------------
8 SHARED DISPOSITIVE POWER
5,001,094(1) (SEE ITEM 4)
- --------------------------------------------------------------------------------
9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
5,001,094(1) (SEE ITEM 4)
- --------------------------------------------------------------------------------
10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES* / /
- --------------------------------------------------------------------------------
11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
9.29%(2)
- --------------------------------------------------------------------------------
12 TYPE OF REPORTING PERSON*
IN
- --------------------------------------------------------------------------------
*SEE INSTRUCTIONS BEFORE FILLING OUT!
- ------------------------
(1) These shares are issuable upon conversion of the Series B Notes at a
conversion price of $3.00 per share of Common Stock, subject to downward
adjustment. The Series B Notes have a term of 10 years.
(2) Assuming issuance of Common Stock upon conversion of the Series B Notes.
<PAGE>
- ---------------------------- ---------------------------
CUSIP No. 218103109 Page 11 of 15 Pages
- ---------------------------- ---------------------------
SCHEDULE 13G
- --------------------------------------------------------------------------------
1 NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON (ENTITIES ONLY)
JOHN F. NICKOLL
- --------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) /x/
(b) / /
- --------------------------------------------------------------------------------
3 SEC USE ONLY
- --------------------------------------------------------------------------------
4 CITIZENSHIP OR PLACE OF ORGANIZATION
CALIFORNIA
- --------------------------------------------------------------------------------
5 SOLE VOTING POWER
- 0 -
NUMBER OF -------------------------------------------------------
SHARES 6 SHARED VOTING POWER
BENEFICIALLY
OWNED BY 5,001,094(1) (SEE ITEM 4)
EACH -------------------------------------------------------
REPORTING 7 SOLE DISPOSITIVE POWER
PERSON
WITH - 0 -
-------------------------------------------------------
8 SHARED DISPOSITIVE POWER
5,001,094(1) (SEE ITEM 4)
- --------------------------------------------------------------------------------
9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
5,001,094(1) (SEE ITEM 4)
- --------------------------------------------------------------------------------
10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES* / /
- --------------------------------------------------------------------------------
11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
9.29%(2)
- --------------------------------------------------------------------------------
12 TYPE OF REPORTING PERSON*
IN
- --------------------------------------------------------------------------------
*SEE INSTRUCTIONS BEFORE FILLING OUT!
- ------------------------
(1) These shares are issuable upon conversion of the Series B Notes at a
conversion price of $3.00 per share of Common Stock, subject to downward
adjustment. The Series B Notes have a term of 10 years.
(2) Assuming issuance of Common Stock upon conversion of the Series B Notes.
<PAGE>
- ---------------------------- ---------------------------
CUSIP No. 218103109 Page 12 of 15 Pages
- ---------------------------- ---------------------------
ITEM 1.
Coram Healthcare Corporation
1125 Seventeenth Street, Suite 1500
Denver, Colorado 80202
ITEM 2.
This Schedule 13G is filed on behalf of The Foothill Group, Inc., a
Delaware Corporation ("Group"), Foothill Capital Corporation, a
California corporation ("Capital"), Foothill Partners II, L.P., a
Delaware limited partnership ("Partners") and M. Edward Stearns,
Karen S. Sandler, Dennis R. Ascher, Peter E. Schwab, David C. Hilton,
the Jeffrey T. Nikora, and the John F. Nickoll (collectively, the
"Managing General Partners"). (Group, Capital, Partners and the
Managing General Partners are collectively referred to as the "Filing
Persons"). Group and the Managing General Partners are the general
partners of Partners. Capital is a wholly-owned subsidiary of Group.
Under the definition of "beneficial owner" ("Beneficial Owner
Definition") provided in Rule 13d-3 of the Exchange Act, Group and the
Managing General Partners may be deemed to beneficially own the shares
of Common Stock owned by Partners by virtue of the fact that Group and
the Managing General Partners, as the general partners of Partners,
share with Partners the voting and dispositive power with respect to
shares of Common Stock held or acquired by Partners.
(a) The Foothill Group, Inc.
Foothill Capital Corporation
Foothill Partners II, L.P.
M. Edward Stearns
Karen S. Sandler
Dennis R. Ascher
Peter E. Schwab
David C. Hilton
Jeffrey T. Nikora
John F. Nickoll
(b) 11111 Santa Monica Boulevard, Suite 1500
Los Angeles, California 90025-3333
(c) United States
(d) Common Stock, $.001 par value
(e) 218103109
ITEM 3.
If This Statement is Filed Pursuant to Rule 13d-1(b), or 13d-2(b) or
(c), Check Whether the Person Filing is a:
(a) / / Broker or dealer registered under Section 15 of the Exchange
Act.
(b) / / Bank as defined in Section 3(a)(6) of the Exchange Act.
(c) / / Insurance company as defined in Section 3(a)(19) of the
Exchange Act.
(d) / / Investment company registered under Section 8 of the
Investment Company Act.
(e) / / An investment adviser in accordance with Rule
13d-1(b)(1)(ii)(E).
(f) / / An employee benefit plan or endowment fund in accordance
with Rule 13d-1(b)(1)(ii)(F).
(g) / / A parent holding company or control person in accordance
with Rule 13d-1(b)(1)(ii)(G).
(h) / / A savings association as defined in Section 3(b) of the
Federal Deposit Insurance Act.
(i) / / A church plan that is excluded from the definition of an
investment company under Section 3(c)(14) of the Investment
Company Act.
<PAGE>
- ---------------------------- ---------------------------
CUSIP No. 218103109 Page 13 of 15 Pages
- ---------------------------- ---------------------------
(j) / / Group, in accordance with Rule 13d-1(b)(1)(ii)(J).
If this statement is filed pursuant to Rule 13d-1(c), check this box /X/
ITEM 4. OWNERSHIP
The ownership of the Filing Persons is as follows:
GROUP
A. Amount Beneficially owned: 5,495,707 (1)
B. Percent of class: 10.12%(2)
C. Number of shares as to which such person has: 5,495,707(1)
1. sole power to vote or to direct the vote: -0-
2. shared power to vote a direct to vote: 5,495,707(1)
3. sole power to vote or to direct to vote: -0-
4. shared power to dispose or to direct the disposition of:
CAPITAL
A. Amount Beneficially owned: 494,613(1)
B. Percent of class: 1.0%(2)
C. Number of shares as to which such person has:
1. sole power to vote or to direct the vote: -0-
2. shared power to vote a direct to vote: 494,613(1)
3. sole power to vote or to direct to vote: -0-
4. shared power to dispose or to direct the disposition of:
494,613(1)
PARTNERS AND EACH OF THE MANAGING GENERAL PARTNERS
A. Amount Beneficially owned: 5,001,094(1)
B. Percent of class: 9.29%(2)
C. Number of shares as to which such person has:
1. sole power to vote or to direct the vote: -0-
2. shared power to vote a direct to vote: 5,001,094
3. sole power to vote or to direct to vote: -0-
4. shared power to dispose or to direct the disposition of:
5,001,094
ITEM 5. OWNERSHIP OF FIVE PERCENT OR LESS OF A CLASS
If this statement is being filed to report the fact that as of the
date hereof the reporting person has ceased to be the beneficial owner
of more than five percent of the class of securities check the
following / /
ITEM 6. OWNERSHIP OF MORE THAN FIVE PERCENT ON BEHALF OF ANOTHER PERSON
Not Applicable
ITEM 7. IDENTIFICATION AND CLASSIFICATION OF THE SUBSIDIARY WHICH
ACQUIRED THE SECURITY BEING REPORTED ON BY THE PARENT HOLDING
COMPANY
- --------------------
(1) These shares are issuable upon conversion of the Company's Series B Notes
at a conversion price of $3.00 per share of Common Stock, subject to
downward adjustment. The Series B Notes have a term of 10 years.
(2) Assuming issuance of Common Stock upon conversion of the Series B Notes.
<PAGE>
- ---------------------------- ---------------------------
CUSIP No. 218103109 Page 14 of 15 Pages
- ---------------------------- ---------------------------
Not Applicable
ITEM 8. IDENTIFICATION AND CLASSIFICATION OF MEMBERS OF THE GROUP
Not Applicable
ITEM 9. NOTICE OF DISSOLUTION OF GROUP
Not Applicable
ITEM 10. CERTIFICATION
By signing below I certify that, to the best of my knowledge and
belief, the securities referred to above were acquired and are not held for the
purpose or with the effect of changing or influencing the control of the issuer
of the securities and were not acquired in connection with or as a participant
in any transaction having that purpose or effect.
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I
certify that the information set forth in this statement is true, complete and
correct.
Dated: July 9, 1997
FOOTHILL CAPITAL CORPORATION
By: /s/ Dennis R. Ascher
---------------------------
Name: Dennis R. Ascher
Title: Vice President
THE FOOTHILL GROUP, INC.
By: /s/ Dennis R. Ascher
---------------------------
Name: Dennis R. Ascher
Title: Vice President
FOOTHILL PARTNERS II, L.P.,
a Delaware limited partnership
By: The Foothill Group, Inc.,
General Partner
By: /s/ Dennis R. Ascher
----------------------------
Name: Dennis R. Ascher
Title: Vice President
<PAGE>
- ---------------------------- --------------------------
CUSIP No. 218103109 Page 15 of 15 Pages
- ---------------------------- --------------------------
MANAGING GENERAL PARTNERS
/s/ M. Edward Stearns
-------------------------------------------------
M. Edward Stearns
/s/ Karen S. Sandler
-------------------------------------------------
Karen S. Sandler
/s/ Dennis R. Ascher
-------------------------------------------------
Dennis R. Ascher
/s/ Peter E. Schwab
-------------------------------------------------
Peter E. Schwab
/s/ David C. Hilton
-------------------------------------------------
David C. Hilton
/s/ Jeffrey T. Nikora
-------------------------------------------------
Jeffrey T. Nikora
/s/ John F. Nickoll
-------------------------------------------------
John F. Nickoll
